Tandem Diabetes Care (TNDM) Debt Ratio (2013 - 2025)

Tandem Diabetes Care (TNDM) posted Debt Ratio of 0.04 for Q1 2025, up 5.11% on a QoQ basis from 0.04 in Q4 2024.

Tandem Diabetes Care (TNDM) Debt Ratio (2013 - 2025) Analysis & Trends

Tandem Diabetes Care's Debt Ratio history runs 8 years deep, the most recent figure standing at 0.04 for Q1 2025.

Quarterly Debt Ratio changed N/A year-over-year to 0.04 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was 0.04 (changed N/A YoY) and the FY2024 annual result came in at 0.04, changed N/A from the prior year.
Debt Ratio was 0.04 for Q1 2025 at Tandem Diabetes Care, up from 0.04 in the prior quarter.
Across five years, Debt Ratio topped out at 0.04 in Q1 2025 and bottomed at 0.04 in Q4 2024.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	0.31
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	0.32
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	0.30
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	0.25
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	0.04
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	0.30
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	0.27
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	0.30
10	Tandem Diabetes Care	1.16 Bn	587.46 Mn	136.79 Mn	-

Historic Data

Download Data

Date	Value
Mar 31, 2025	0.04
Dec 31, 2024	0.04
Sep 30, 2024	0.04
Jun 30, 2024	0.04
Jun 30, 2018	0.49
Mar 31, 2018	0.53
Dec 31, 2017	0.80
Sep 30, 2017	0.86
Jun 30, 2017	0.76
Mar 31, 2017	0.65
Dec 31, 2016	0.70
Sep 30, 2016	0.49
Jun 30, 2016	0.41
Mar 31, 2016	0.37
Dec 31, 2015	0.23
Sep 30, 2015	0.23
Jun 30, 2015	0.21
Mar 31, 2015	0.19
Dec 31, 2014	0.28
Sep 30, 2014	0.25